Sign In
Buy CPRX
$31.49
+0 (+0%)
At Close: Jul 31, 2026
New Strong Buy Stocks for March 4th
06:11am, Wednesday, 04'th Mar 2026
ORN, LRCX, GMED, MYRG and CPRX have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2026.
Catalyst Pharmaceuticals Q4 Earnings Call Highlights
04:50am, Sunday, 01'st Mar 2026
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported fourth-quarter and full-year 2025 results that management said reflected continued revenue growth across its commercial portfolio, led by Firdapse and
Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript
03:27pm, Thursday, 26'th Feb 2026
Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2025 Earnings Call Transcript
Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y
11:11am, Thursday, 26'th Feb 2026
CPRX tops Q4 estimates as Firdapse and Agamree sales jump, lifting 2025 results and driving upbeat 2026 revenue guidance.
Catalyst (CPRX) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 26'th Feb 2026
The headline numbers for Catalyst (CPRX) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
04:07pm, Wednesday, 25'th Feb 2026
Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total Revenues Q4 2025 Total Revenues of $152.6 Million, Fueled by 18.3% FI
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
10:50am, Tuesday, 24'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Ahead of Catalyst (CPRX) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:15am, Tuesday, 24'th Feb 2026
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Catalyst (CPRX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qu
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
08:03am, Tuesday, 24'th Feb 2026
CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Catalyst Pharmaceuticals: Clear Path Forward For Growth In 2 FDA-Approved Drugs
11:39am, Thursday, 19'th Feb 2026
Catalyst Pharmaceuticals management asserts a $1B+ LEMS market opportunity, estimating 3,600–5,400 addressable patients, with growth driven by improved diagnosis and market penetration. Recent prese
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
10:41am, Thursday, 19'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for
11:05am, Wednesday, 18'th Feb 2026
Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
08:03am, Wednesday, 11'th Feb 2026
The Company will Host a Conference Call and Webcast on Thursday, February 26, 2026, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, February 26, 2026, at 8:30 AM ET
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 03'rd Feb 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 28'th Jan 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
